When people hear “metastatic cancer,” many assume it is always a severe, terminal condition, but prostate cancer is a bit ...

Daewoong Pharmaceutical announced the Korean launch of Fexuclue Tablets 20mg (fexuprazan hydrochloride) on Monday.This marks ...

Hanmi Pharmaceutical has introduced two new low-dose variants (5/50/2.5/10mg, 5/100/2.5/10mg) of Amosartan XQ -- an ...

Yuyu Pharma said on Monday that it has made a strategic investment in Dalan Animal Health, a U.S. biotechnology company ...

CHICAGO, Ill. -- By Kim Ji-hye / Korea Biomedical correspondent -- They met in the middle of the exhibit hall at Chicago’s ...

GSK’s Jemperli has secured its position as a standard treatment option in endometrial cancer following Korea’s decision to ...

GC Holdings announced Monday that it has appointed Park So-young as the new head of its Strategic Planning Office.Park is a ...

Last week, the Ministry of Health and Welfare announced plans to improve the drug pricing system, aiming to establish an ...

AstraZeneca Korea's C5 inhibitor Ultomiris (ravulizumab) became reimbursed by the national health insurance for adult ...

The Korean Stroke Society has proposed that to reduce the problem of stroke patients being shuttled between emergency rooms, ...

A large-scale study led by Severance Hospital has confirmed that the American Heart Association (AHA)’s PREVENT (Predicting Risk of Cardiovascular Disease EVENTs) model accurately predicts cardiovascu ...

CHICAGO, Ill. -- By Kim Ji-hye / Korea Biomedical correspondent -- Neurophet, a provider of AI solutions for brain disorders, said Tuesday it has appointed Josh Cohen -- who previously held roles at g ...